|
CIAPIN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.70579999967136E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.56005999999431E-05 |
| Normal-vs-Stage2 |
8.900400E-01 |
| Normal-vs-Stage3 |
3.48249999948536E-07 |
| Normal-vs-Stage4 |
9.13740194619095E-11 |
| Stage1-vs-Stage2 |
1.149740E-02 |
| Stage1-vs-Stage3 |
7.893600E-02 |
| Stage1-vs-Stage4 |
2.449300E-04 |
| Stage2-vs-Stage3 |
1.238230E-03 |
| Stage2-vs-Stage4 |
2.35659999999749E-05 |
| Stage3-vs-Stage4 |
9.471700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.31009999995813E-06 |
| Normal-vs-AfricanAmerican |
1.89312999999691E-05 |
| Normal-vs-Asian |
8.12390000000107E-05 |
| Caucasian-vs-AfricanAmerican |
1.502760E-01 |
| Caucasian-vs-Asian |
6.239400E-01 |
| AfricanAmerican-vs-Asian |
3.523600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.87659999999679E-05 |
| Normal-vs-Female |
1.16829999996515E-06 |
| Male-vs-Female |
7.821000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.31689999996565E-06 |
| Normal-vs-Age(41-60Yrs) |
3.91980000002956E-06 |
| Normal-vs-Age(61-80Yrs) |
4.902800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.522480E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.576600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.168000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.562600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.557200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.260400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.738000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.294100E-02 |
| Classical-VS-Follicular |
9.456000E-02 |
| Classical-VS-Other |
5.536000E-01 |
| Classical-VS-Normal |
1.05439999997792E-06 |
| Tall-VS-Follicular |
2.322300E-03 |
| Tall-VS-Other |
7.710200E-01 |
| Tall-VS-Normal |
1.09479999954587E-07 |
| Follicular-VS-Other |
3.215000E-01 |
| Follicular-VS-Normal |
5.080300E-02 |
| Other-VS-Normal |
1.336960E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.261830E-03 |
| Normal-vs-N1 |
6.83470002815767E-09 |
| N0-vs-N1 |
7.160500E-04 |
|
|
